Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a theme (Q40423093)

20 September 2017

1 reference

title

Long-term aspirin in the prevention of cardiovascular disorders. Recent developments and variations on a theme (English)

1 reference

20 September 2017

1 reference

F Catella-Lawson

1

1 reference

20 September 2017

G A FitzGerald

series ordinal

2

1 reference

20 September 2017

publication date

1 August 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

13

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

69-75

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199513020-00001

20 September 2017

exact match

0 references

cites work

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses

1 reference

12 December 2020

Preliminary report of the Stroke Prevention in Atrial Fibrillation Study

1 reference

12 December 2020

TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue

1 reference

12 December 2020

Human cyclooxygenase-2 cDNA

1 reference

12 December 2020

Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disea

1 reference

12 December 2020

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

1 reference

12 December 2020

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin

1 reference

12 December 2020

Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

1 reference

12 December 2020

Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study

1 reference

12 December 2020

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

12 December 2020

Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells

1 reference

12 December 2020

Twelve-Year Comparison of a Bjork–Shiley Mechanical Heart Valve with Porcine Bioprostheses

1 reference

12 December 2020

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

12 December 2020

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

12 December 2020

Prevention of acute complications after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

12 December 2020

A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke

1 reference

12 December 2020

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group

1 reference

12 December 2020

The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials

1 reference

12 December 2020

Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.

1 reference

12 December 2020

Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group

1 reference

12 December 2020

The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration.

1 reference

12 December 2020

Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.

1 reference

12 December 2020

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

1 reference

12 December 2020

1 reference

12 December 2020

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

12 December 2020

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

12 December 2020

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

12 December 2020

Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases

1 reference

12 December 2020

Aspirin, NSAIDs, and risk reduction of colorectal cancer. The problem is translation

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells

1 reference

12 December 2020

Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

1 reference

12 December 2020

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.

1 reference

12 December 2020

Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis

1 reference

12 December 2020

Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme

1 reference

12 December 2020

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

12 December 2020

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

1 reference

12 December 2020

Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.

1 reference

12 December 2020

Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.

1 reference

12 December 2020

Extended inhibition of platelet aggregation with the orally active platelet inhibitor SC-54684A

1 reference

12 December 2020

Aspirin use and reduced risk of fatal colon cancer

1 reference

12 December 2020

10.2165/00002018-199513020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1052720262

0 references

1 reference